2017 Top Investment Picks – Q3 Update

At the beginning of the year, I put together a list of top picks from the investment community and track them on this website. This is just meant to be a fun exercise to see how the picks do. As part of the process, I intend do provide quarterly updates on the picks to see how they are doing. This is the update after Q3.

Note that you can track the progress anytime by going to the Stock Picks page.

At the end of Q3, the top picks stand as shown below.

Blog reader Guy Knight leads the way with his pick of Starpharma Holdings Ltd (ASX:SPL). This is what he had to say about the pick:

“My personal choice for 2017 is an Australian nanotech company called Starpharma. In the long term, its dendrimer technology shows huge promise to make a wide variety of drugs work better at lower dosages and with fewer side effects. Should this prove to be the case, these qualities could improve existing drugs that are off patent, thereby qualifying them as new formulations and worthy of new patents. In the short term, the company has multiple products newly for sale or for some time in 2017. The first product is its Vivagel-coated condoms that that have been shown in the lab to kill viruses such as HIV and HPV. These are for sale in Australia and approved for sale in Canada, Iran, and China with likely more countries to follow. Another product that will be for sale soon is Vivagel to treat bacterial vaginosis. It is a new class of treatment that appears to have a huge demand, since current treatments are severely lacking. In addition, they have clinical trials ongoing, with milestone payments from Astrazenica that will come due. It’s a speculative investment in a currently unprofitable company that may very well show its first profit this year. I own shares in this company.”

Congrats on the performance so far, Guy. Up almost 74% up YTD, that’s a fantastic rate of return. Good to see some all round great numbers from the picks, with only a handful of picks showing red.

Special mention about the pick from DivHut. His pick, Care Capital Properties Inc (CCP), which was originally spun off from Ventas Inc (VTR) a couple of years ago, merged with Sabra Health Care REIT (SBRA) in Q3.

Happy Hunting

R2R

6 thoughts on “2017 Top Investment Picks – Q3 Update

    • Thats right, DGI. Some great stock pickers on this list here 🙂 Who would’ve thought that large caps like UL and AAPL would beat out many of the smaller players.

      Thanks for stopping by
      R2R

    • I remember that NVO was your close second for the pick and you were talking a lot about it at the start of the year. Vasco might still make a comeback….theres 3 more months left in this year 🙂

      You have a great wknd too
      R2R

    • Glad to hear you are doing well, Bernz. A lot of the pickers in this list are dividend focused, which keeps them away from tech companies. There isnt much history of tech companies being long term dividend payers and growers, save a few names.

      R2R

Leave a Reply

Your email address will not be published. Required fields are marked *